These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo. Pennati M, Binda M, De Cesare M, Pratesi G, Folini M, Citti L, Daidone MG, Zunino F, Zaffaroni N. Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461 [Abstract] [Full Text] [Related]
8. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [Abstract] [Full Text] [Related]
10. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA. Cheng B, Yang X, Han Z, An L, Liu S. Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043 [Abstract] [Full Text] [Related]
15. Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line. Asechi H, Hatano E, Nitta T, Tada M, Iwaisako K, Tamaki N, Nagata H, Narita M, Yanagida A, Ikai I, Uemoto S. Int J Oncol; 2010 Jul; 37(1):89-96. PubMed ID: 20514400 [Abstract] [Full Text] [Related]
16. Downregulation of survivin expression and elevation of caspase-3 activity involved in pitavastatin-induced HepG 2 cell apoptosis. Wang J, Xu Z, Zhang M. Oncol Rep; 2007 Aug; 18(2):383-7. PubMed ID: 17611660 [Abstract] [Full Text] [Related]